Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

le Moore, David F, Altarescu, Gheona, Herscovitch, Peter, Schiffmann, Raphael
Foilsithe 2002

Increased Signal Intensity in the Pulvinar on T1-Weighted Images: A Pathognomonic MR Imaging Sign of Fabry Disease

le Moore, David F., Ye, Frank, Schiffmann, Raphael, Butman, John A.
Foilsithe in AJNR Am J Neuroradiol (2003)

Clinical Use of Diffusion-Tensor Imaging for Diseases Causing Neuronal and Axonal Damage

le Uluğ, Aziz M., Moore, David F., Bojko, Aviva S., Zimmerman, Robert D.
Foilsithe in AJNR Am J Neuroradiol (1999)

Hepatitis C and recurrent treatment-resistant acute ischemic stroke

le Saxsena, Aneeta, Tarsia, Joseph, Dunn, Casey, Aysenne, Aimee, Shah, Basil, Moore, David F.
Foilsithe 2013

Arterial Wall Properties and Womersley Flow in Fabry Disease

le Moore, David F, Altarescu, Gheona, Pursley, Randall, Campia, Umberto, Panza, Julio A, Dimitriadis, Emilios, Schiffmann, Raphael
Foilsithe 2002

An animal-to-human scaling law for blast-induced traumatic brain injury risk assessment

le Jean, Aurélie, Nyein, Michelle K., Zheng, James Q., Moore, David F., Joannopoulos, John D., Radovitzky, Raúl
Foilsithe 2014

Enhanced Endothelium-Dependent Vasodilation in Fabry Disease

le Altarescu, Gheona, Moore, David F., Pursley, Randall, Campia, Umberto, Goldstein, Seth, Bryant, Melissa, Panza, Julio A., Schiffmann, Raphael
Foilsithe in Stroke (2001)

Reply to Moss et al.: Military and medically relevant models of blast-induced traumatic brain injury vs. ellipsoidal heads and helmets

le Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul
Foilsithe 2011

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

le Shen, Jin-Song, Meng, Xing-Li, Moore, David F., Quirk, Jane M., Shayman, James A., Schiffmann, Raphael, Kaneski, Christine R.
Foilsithe 2008

In silico investigation of intracranial blast mitigation with relevance to military traumatic brain injury

le Nyein, Michelle K., Jason, Amanda M., Yu, Li, Pita, Claudio M., Joannopoulos, John D., Moore, David F., Radovitzky, Raul A.
Foilsithe 2010

Skin-impedance in Fabry Disease: A prospective, controlled, non-randomized clinical study

le Gupta, Surya N, Ries, Markus, Murray, Gary J, Quirk, Jane M, Brady, Roscoe O, Lidicker, Jeffrey R, Schiffmann, Raphael, Moore, David F
Foilsithe 2008

Proteomics of specific treatment-related alterations in Fabry disease: A strategy to identify biological abnormalities

le Moore, David F., Krokhin, Oleg V., Beavis, Ronald C., Ries, Markus, Robinson, Chevalia, Goldin, Ehud, Brady, Roscoe O., Wilkins, John A., Schiffmann, Raphael
Foilsithe 2007

Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach

le Moore, David F., Gelderman, Monique P., Ferreira, Paulo A., Fuhrmann, Steven R., Yi, Haiqing, Elkahloun, Abdel, Lix, Lisa M., Brady, Roscoe O., Schiffmann, Raphael, Goldin, Ehud
Foilsithe 2007

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?

le Kateb, Babak, Chiu, Katherine, Black, Keith L., Yamamoto, Vicky, Khalsa, Bhavraj, Ljubimova, Julia Y., Ding, Hui, Patil, Rameshwar, Portilla-Arias, Jose Antonio, Modo, Mike, Moore, David F., Farahani, Keyvan, Okun, Michael S., Prakash, Neal, Neman, Josh, Ahdoot, Daniel, Grundfest, Warren, Nikzad, Shouleh, Heiss, John D.
Foilsithe 2010